Champions Oncology Inc Stock
Your prediction
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | - | 0.901% | 10.891% | 17.647% | -3.448% | 43.590% | -36.364% |
| Ardelyx Inc. | 0.450% | 26.964% | 32.366% | 34.396% | 35.546% | 146.456% | 23.939% |
| Evolus Inc | -1.240% | -15.439% | -18.992% | -49.792% | -11.560% | -36.993% | 32.856% |
| ImmunityBio Inc. | 0.850% | 15.544% | 7.355% | -15.209% | 14.916% | -51.404% | -82.977% |
News
3 Dividend Champion Stocks I'm Watching in 2025
If you are looking for high-yield stocks in a stock market that is hovering near all-time highs, a good place to start your search is with reliable dividend payers.
Dividend Champions fit the bill
Keep an Eye on These 3 Dividend Champion Stocks in 2025
A streak lasting decades is noteworthy. Whether it's a silver wedding anniversary, a quarter century of work, or The Simpsons' 37-year run, these show stability and success.
You can find examples in
7 Best Dividend Champions to Buy Now
Dividend Champions are long-term winners. These companies have grown their dividends for at least 25 straight years. They don't have to be members of the S&P 500 (SNPINDEX: ^GSPC), which broadens